Dasyo Welcomes Medical Aesthetics Industry Icon Domenic (Dom) Serafino as Executive Chair
Dasyo, a pioneer in noninvasive medical aesthetics technologies, has appointed Domenic (Dom) Serafino as Executive Board Chair. Serafino brings extensive industry experience, having co-founded and led Venus Concept Inc. to over $100 million in annual revenues. He was also instrumental in Syneron Medical Corp's successful IPO. Dasyo, funded by the Israel Innovation Authority and The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), is developing a groundbreaking non-surgical breast lift product using proprietary technology for noninvasive directional skin tightening. This appointment is expected to significantly enhance Dasyo's strategic direction and growth potential in the aesthetics medical device sector.
Dasyo, pioniere nelle tecnologie estetiche mediche non invasive, ha nominato Domenic (Dom) Serafino come Presidente del Consiglio Esecutivo. Serafino porta con sé una vasta esperienza nel settore, avendo co-fondato e guidato Venus Concept Inc. fino a oltre 100 milioni di dollari di fatturato annuo. È stato inoltre fondamentale per il successo dell'IPO di Syneron Medical Corp. Dasyo, finanziata dall'Autorità per l'Innovazione di Israele e dal The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), sta sviluppando un prodotto innovativo per il sollevamento del seno non chirurgico utilizzando una tecnologia proprietaria per il rassodamento della pelle non invasivo direzionale. Questa nomina si prevede avrà un impatto significativo sulla direzione strategica e sul potenziale di crescita di Dasyo nel settore dei dispositivi medici estetici.
Dasyo, pionero en tecnologías estéticas médicas no invasivas, ha nombrado a Domenic (Dom) Serafino como Presidente del Consejo Ejecutivo. Serafino aporta una amplia experiencia en la industria, habiendo cofundado y liderado Venus Concept Inc. hasta obtener más de 100 millones de dólares en ingresos anuales. También fue fundamental en la exitosa OPI de Syneron Medical Corp. Dasyo, financiado por la Autoridad de Innovación de Israel y The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), está desarrollando un producto revolucionario para el levantamiento del seno no quirúrgico utilizando tecnología propietaria para el tensado direccional de la piel no invasivo. Se espera que este nombramiento mejore significativamente la dirección estratégica y el potencial de crecimiento de Dasyo en el sector de dispositivos médicos estéticos.
다소(Dasyo)는 비침습적인 의료 미용 기술의 선두주자로서 도메닉(Dom) 세라피노를 경영 이사회 의장으로 임명했습니다. 세라피노는 1억 달러 이상의 연간 수익을 기록한 비너스 컨셉(Venus Concept Inc.)의 공동 창립자이자 CEO로서 방대한 산업 경험을 가지고 있습니다. 그는 또한 시너론 메디컬 코퍼레이션(Syneron Medical Corp)의 성공적인 IPO에 중요한 역할을 했습니다. 다소는 이스라엘 혁신청과 트렌드라인스 그룹(The Trendlines Group)(SGX: 42T)(OTCQX: TRNLY)의 지원을 받아 비수술 유방 리프트 제품을 개발 중이며, 이는 비침습적인 방향성 피부 탄력을 위한 독자적인 기술을 사용하고 있습니다. 이번 임명은 다소의 전략적 방향성과 의료 미용 기기 분야에서의 성장 잠재력을 크게 향상시킬 것으로 예상됩니다.
Dasyo, pionnier dans les technologies esthétiques médicales non invasives, a nommé Domenic (Dom) Serafino président du conseil d'administration. Serafino apporte une vaste expérience dans le secteur, ayant cofondé et dirigé Venus Concept Inc. pour plus de 100 millions de dollars de revenus annuels. Il a également joué un rôle clé dans l'introduction en bourse réussie de Syneron Medical Corp. Dasyo, financé par l'Autorité israélienne de l'innovation et The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), développe un produit révolutionnaire de lifting mammaire non chirurgical utilisant une technologie propriétaire pour un raffermissement directionnel de la peau non invasif. Cette nomination devrait considérablement améliorer l'orientation stratégique et le potentiel de croissance de Dasyo dans le secteur des dispositifs médicaux esthétiques.
Dasyo, ein Pionier in den nicht-invasiven medizinischen Ästhetiktechnologien, hat Domenic (Dom) Serafino zum Vorsitzenden des Vorstands ernannt. Serafino bringt umfangreiche Branchenerfahrung mit, nachdem er Venus Concept Inc. mit über 100 Millionen US-Dollar Jahresumsatz mitbegründet und geleitet hat. Er war auch entscheidend für den erfolgreichen Börsengang von Syneron Medical Corp. Dasyo, finanziert von der Israel Innovation Authority und The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), entwickelt ein bahnbrechendes nicht-chirurgisches Brustliftprodukt unter Verwendung einer proprietären Technologie zur nicht-invasiven, richtungsgebundenen Hautstraffung. Diese Ernennung wird voraussichtlich die strategische Ausrichtung und das Wachstumspotenzial von Dasyo im Bereich der ästhetischen Medizingeräte erheblich verbessern.
- Appointment of industry veteran Domenic Serafino as Executive Board Chair
- Serafino's track record includes leading Venus Concept Inc. to over $100 million in annual revenues
- Development of innovative non-surgical breast lift product
- Funding support from Israel Innovation Authority and The Trendlines Group
- None.
MISGAV,
Dasyo is developing groundbreaking non-surgical breast lifts product using proprietary technology for noninvasive directional skin tightening. Dasyo is funded by the Israel Innovation Authority and The Trendlines Group (SGX: 42T) (OTCQX: TRNLY).
Dom's impressive track record includes Co-Founder and CEO of Venus Concept Inc. from inception in 2010 through 2022. He led the company from startup to over
He was part of the start-up executive team at Syneron Medical Corp acting as its President of
Dom also served as President and Chief Operating Officer of Sigmacon Group,
"Welcoming Dom as Executive Chair is a transformative step for Dasyo," stated Emri Valtzer, CEO of Dasyo. "His visionary leadership and unmatched expertise in the aesthetics medical device arena are perfectly aligned with our ambitious objectives. We are thrilled to have him on our board and are eager to harness his insights to propel our innovative vision."
"I am honored to join Dasyo as Executive Chair," shared Dom Serafino. "Dasyo's dedication to pioneering aesthetics medical technologies is truly commendable. After researching and working with many different technologies over the years, I am confident that the team at Dasyo has truly developed something new and innovative in the directional skin tightening category, especially in non-surgical breast lifting."
Serafino's appointment significantly enhances Dasyo's strategic direction and growth potential, reinforcing the company's commitment to innovation and excellence in the noninvasive aesthetics medical device sector.
Contact:
Emri Valtzer
CEO Dasyo
emri@dasyo-aesthetics.com
Photo - https://mma.prnewswire.com/media/2465999/Dominic_Serafino.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/dasyo-welcomes-medical-aesthetics-industry-icon-domenic-dom-serafino-as-executive-chair-302202516.html
SOURCE Dasyo
FAQ
What is Dasyo's main product in development?
Who has been appointed as Dasyo's Executive Board Chair?
What is Domenic Serafino's background in the medical aesthetics industry?
Who are the investors backing Dasyo?
